EMEA

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

News

Catalent Opens Cell Therapy Facility in Belgium

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.

News

UK Votes to Remain Part of EMA

Topics • Chemistry

Helping Customers Meet Market Requirements

Top-Feature

Nova-Institut GmbH

Brenntag Downsizes Management Board, Retains Both Divisions

Virtual Event

Bioprocess Forum

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

EMEA

Pharma Outlook 2025

Catalent Opens Cell Therapy Facility in Belgium

UK Votes to Remain Part of EMA

Helping Customers Meet Market Requirements

Top-Feature

Advanced Recycling Conference 2025: New Paths to the Circular Economy

API Manufacturing

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

Virtual Event

Downstream Purification

EMEA

Pharma Outlook 2025

Catalent Opens Cell Therapy Facility in Belgium

UK Votes to Remain Part of EMA

Helping Customers Meet Market Requirements

Top-Feature

Advanced Recycling Conference 2025: New Paths to the Circular Economy

API Manufacturing

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

Virtual Event

Downstream Purification

Newsletter & e-edition